These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24637659)

  • 1. Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials.
    Paoloni M; Webb C; Mazcko C; Cherba D; Hendricks W; Lana S; Ehrhart EJ; Charles B; Fehling H; Kumar L; Vail D; Henson M; Childress M; Kitchell B; Kingsley C; Kim S; Neff M; Davis B; Khanna C; Trent J
    PLoS One; 2014; 9(3):e90028. PubMed ID: 24637659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-site feasibility study for personalized medicine in canines with osteosarcoma.
    Monks NR; Cherba DM; Kamerling SG; Simpson H; Rusk AW; Carter D; Eugster E; Mooney M; Sigler R; Steensma M; Grabinski T; Marotti KR; Webb CP
    J Transl Med; 2013 Jul; 11():158. PubMed ID: 23815880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
    Berlow NE; Rikhi R; Geltzeiler M; Abraham J; Svalina MN; Davis LE; Wise E; Mancini M; Noujaim J; Mansoor A; Quist MJ; Matlock KL; Goros MW; Hernandez BS; Doung YC; Thway K; Tsukahara T; Nishio J; Huang ET; Airhart S; Bult CJ; Gandour-Edwards R; Maki RG; Jones RL; Michalek JE; Milovancev M; Ghosh S; Pal R; Keller C
    BMC Cancer; 2019 Jun; 19(1):593. PubMed ID: 31208434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards the Delivery of Precision Veterinary Cancer Medicine.
    Katogiritis A; Khanna C
    Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):809-818. PubMed ID: 31256903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
    Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
    Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine Oncopanel: A capture-based, NGS platform for evaluating the mutational landscape and detecting putative driver mutations in canine cancers.
    Wang G; Wu M; Durham AC; Mason NJ; Roth DB
    Vet Comp Oncol; 2022 Mar; 20(1):91-101. PubMed ID: 34286913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision oncology based on omics data: The NCT Heidelberg experience.
    Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
    Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.
    Paoloni MC; Tandle A; Mazcko C; Hanna E; Kachala S; Leblanc A; Newman S; Vail D; Henry C; Thamm D; Sorenmo K; Hajitou A; Pasqualini R; Arap W; Khanna C; Libutti SK
    PLoS One; 2009; 4(3):e4972. PubMed ID: 19330034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study.
    Sicklick JK; Kato S; Okamura R; Schwaederle M; Hahn ME; Williams CB; De P; Krie A; Piccioni DE; Miller VA; Ross JS; Benson A; Webster J; Stephens PJ; Lee JJ; Fanta PT; Lippman SM; Leyland-Jones B; Kurzrock R
    Nat Med; 2019 May; 25(5):744-750. PubMed ID: 31011206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.
    Diaz Z; Aguilar-Mahecha A; Paquet ER; Basik M; Orain M; Camlioglu E; Constantin A; Benlimame N; Bachvarov D; Jannot G; Simard MJ; Chabot B; Gologan A; Klinck R; Gagnon-Kugler T; Lespérance B; Samson B; Kavan P; Alcindor T; Dalfen R; Lan C; Chabot C; Buchanan M; Przybytkowski E; Qureshi S; Rousseau C; Spatz A; Têtu B; Batist G
    Mod Pathol; 2013 Nov; 26(11):1413-24. PubMed ID: 23743930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis.
    Kim ST; Lee J; Hong M; Park K; Park JO; Ahn T; Park SH; Park YS; Lim HY; Sun JM; Ahn JS; Ahn MJ; Kim HC; Sohn TS; Choi DI; Cho JH; Heo JS; Kwon W; Uhm SW; Lee H; Min BH; Hong SN; Kim DH; Jung SH; Park W; Kim KM; Kang WK; Park K
    Oncotarget; 2015 Oct; 6(32):33358-68. PubMed ID: 26396172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology.
    London CA; Gardner H; Zhao S; Knapp DW; Utturkar SM; Duval DL; Chambers MR; Ostrander E; Trent JM; Kuffel G
    Vet Comp Oncol; 2023 Dec; 21(4):565-577. PubMed ID: 37778398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics-Enabled Precision Medicine for Cancer.
    Roos A; Byron SA
    Cancer Treat Res; 2019; 178():137-169. PubMed ID: 31209844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience.
    Seet AOL; Tan AC; Tan TJ; Ng MCH; Tai DWM; Lam JYC; Tan GS; Gogna A; Too CW; Tan BS; Takano A; Lim A; Lim TH; Lim ST; Dent RA; Ang MK; Yap YS; Tan IBH; Choo SP; Toh CK; Lim EH; Farid M; Skanderup AJ; Iyer NG; Lim WT; Tan EH; Lim TKH; Tan DSW
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression.
    Paoloni M; Davis S; Lana S; Withrow S; Sangiorgi L; Picci P; Hewitt S; Triche T; Meltzer P; Khanna C
    BMC Genomics; 2009 Dec; 10():625. PubMed ID: 20028558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative expression pathway analysis of human and canine mammary tumors.
    Uva P; Aurisicchio L; Watters J; Loboda A; Kulkarni A; Castle J; Palombo F; Viti V; Mesiti G; Zappulli V; Marconato L; Abramo F; Ciliberto G; Lahm A; La Monica N; de Rinaldis E
    BMC Genomics; 2009 Mar; 10():135. PubMed ID: 19327144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics workflows for clinical applications in precision oncology.
    Jäger N
    Semin Cancer Biol; 2022 Sep; 84():103-112. PubMed ID: 33476720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer.
    Xu C; Nikolova O; Basom RS; Mitchell RM; Shaw R; Moser RD; Park H; Gurley KE; Kao MC; Green CL; Schaub FX; Diaz RL; Swan HA; Jang IS; Guinney J; Gadi VK; Margolin AA; Grandori C; Kemp CJ; Méndez E
    Clin Cancer Res; 2018 Jun; 24(12):2828-2843. PubMed ID: 29599409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.